_version_ 1868266237324165121
author Niu, Guang-Hao
Hsiao, Wan-Chi
Lee, Po-Hsun
Zheng, Li-Guo
Yang, Yu-Shao
Huang, Wei-Cheng
Hsieh, Chih-Chien
Chiu, Tai-Yu
Wang, Jing-Ya
Chen, Ching-Ping
Huang, Chen-Lung
You, May-Su
Kuo, Yi-Ping
Wang, Chien-Ming
Wen, Zhi-Hong
Yu, Guann-Yi
Chen, Chiung-Tong
Chi, Ya-Hui
Tung, Chun-Wei
Hsu, Shu-Ching
Yeh, Teng-Kuang
Sung, Ping-Jyun
Zhang, Mingzi M
Tsou, Lun Kelvin
author_facet Niu, Guang-Hao
Hsiao, Wan-Chi
Lee, Po-Hsun
Zheng, Li-Guo
Yang, Yu-Shao
Huang, Wei-Cheng
Hsieh, Chih-Chien
Chiu, Tai-Yu
Wang, Jing-Ya
Chen, Ching-Ping
Huang, Chen-Lung
You, May-Su
Kuo, Yi-Ping
Wang, Chien-Ming
Wen, Zhi-Hong
Yu, Guann-Yi
Chen, Chiung-Tong
Chi, Ya-Hui
Tung, Chun-Wei
Hsu, Shu-Ching
Yeh, Teng-Kuang
Sung, Ping-Jyun
Zhang, Mingzi M
Tsou, Lun Kelvin
Niu, Guang-Hao
Hsiao, Wan-Chi
Lee, Po-Hsun
Zheng, Li-Guo
Yang, Yu-Shao
Huang, Wei-Cheng
Hsieh, Chih-Chien
Chiu, Tai-Yu
Wang, Jing-Ya
Chen, Ching-Ping
Huang, Chen-Lung
You, May-Su
Kuo, Yi-Ping
Wang, Chien-Ming
Wen, Zhi-Hong
Yu, Guann-Yi
Chen, Chiung-Tong
Chi, Ya-Hui
Tung, Chun-Wei
Hsu, Shu-Ching
Yeh, Teng-Kuang
Sung, Ping-Jyun
Zhang, Mingzi M
Tsou, Lun Kelvin
collection PubMed - marine biology
contents Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid. Niu, Guang-Hao Hsiao, Wan-Chi Lee, Po-Hsun Zheng, Li-Guo Yang, Yu-Shao Huang, Wei-Cheng Hsieh, Chih-Chien Chiu, Tai-Yu Wang, Jing-Ya Chen, Ching-Ping Huang, Chen-Lung You, May-Su Kuo, Yi-Ping Wang, Chien-Ming Wen, Zhi-Hong Yu, Guann-Yi Chen, Chiung-Tong Chi, Ya-Hui Tung, Chun-Wei Hsu, Shu-Ching Yeh, Teng-Kuang Sung, Ping-Jyun Zhang, Mingzi M Tsou, Lun Kelvin Animals Diterpenes Humans Administration, Oral Membrane Proteins Mice Colitis Biological Availability Mice, Inbred C57BL Macrocyclic Compounds STING Protein Pharmacological inhibition of the cGAS-STING-controlled innate immune pathway is an emerging therapeutic strategy for a myriad of inflammatory diseases. Here, we report as an orally bioavailable covalent STING inhibitor. Late-stage diversification of the briarane-type diterpenoid excavatolide B allowed the installation of solubility-enhancing functional groups while enhancing its activity as a covalent STING inhibitor against multiple human STING variants, including the S154 variant responsible for a genetic autoimmune disease. Selectively engaging the membrane-proximal Cys91 residue of STING, dose-dependently inhibited cGAS-STING signaling and type I interferon responses in cells and in vivo. Moreover, orally administered exhibited on-target engagement in vivo and markedly reversed key pathological features in a delayed treatment of the acute colitis mouse model. Our study provided proof of concept that the synthetic briarane analog serves as a safe, site-selective, and orally active covalent STING inhibitor and devises a regimen that allows long-term systemic administration.
format Artículo científico
id pubmed_40014799
institution PubMed
language en
publishDate 2025
publisher Journal of medicinal chemistry
record_format pubmed
spellingShingle Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid.
Niu, Guang-Hao
Hsiao, Wan-Chi
Lee, Po-Hsun
Zheng, Li-Guo
Yang, Yu-Shao
Huang, Wei-Cheng
Hsieh, Chih-Chien
Chiu, Tai-Yu
Wang, Jing-Ya
Chen, Ching-Ping
Huang, Chen-Lung
You, May-Su
Kuo, Yi-Ping
Wang, Chien-Ming
Wen, Zhi-Hong
Yu, Guann-Yi
Chen, Chiung-Tong
Chi, Ya-Hui
Tung, Chun-Wei
Hsu, Shu-Ching
Yeh, Teng-Kuang
Sung, Ping-Jyun
Zhang, Mingzi M
Tsou, Lun Kelvin
Animals
Diterpenes
Humans
Administration, Oral
Membrane Proteins
Mice
Colitis
Biological Availability
Mice, Inbred C57BL
Macrocyclic Compounds
STING Protein
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid. Niu, Guang-Hao Hsiao, Wan-Chi Lee, Po-Hsun Zheng, Li-Guo Yang, Yu-Shao Huang, Wei-Cheng Hsieh, Chih-Chien Chiu, Tai-Yu Wang, Jing-Ya Chen, Ching-Ping Huang, Chen-Lung You, May-Su Kuo, Yi-Ping Wang, Chien-Ming Wen, Zhi-Hong Yu, Guann-Yi Chen, Chiung-Tong Chi, Ya-Hui Tung, Chun-Wei Hsu, Shu-Ching Yeh, Teng-Kuang Sung, Ping-Jyun Zhang, Mingzi M Tsou, Lun Kelvin Animals Diterpenes Humans Administration, Oral Membrane Proteins Mice Colitis Biological Availability Mice, Inbred C57BL Macrocyclic Compounds STING Protein Pharmacological inhibition of the cGAS-STING-controlled innate immune pathway is an emerging therapeutic strategy for a myriad of inflammatory diseases. Here, we report as an orally bioavailable covalent STING inhibitor. Late-stage diversification of the briarane-type diterpenoid excavatolide B allowed the installation of solubility-enhancing functional groups while enhancing its activity as a covalent STING inhibitor against multiple human STING variants, including the S154 variant responsible for a genetic autoimmune disease. Selectively engaging the membrane-proximal Cys91 residue of STING, dose-dependently inhibited cGAS-STING signaling and type I interferon responses in cells and in vivo. Moreover, orally administered exhibited on-target engagement in vivo and markedly reversed key pathological features in a delayed treatment of the acute colitis mouse model. Our study provided proof of concept that the synthetic briarane analog serves as a safe, site-selective, and orally active covalent STING inhibitor and devises a regimen that allows long-term systemic administration.
title Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid.
topic Animals
Diterpenes
Humans
Administration, Oral
Membrane Proteins
Mice
Colitis
Biological Availability
Mice, Inbred C57BL
Macrocyclic Compounds
STING Protein
url https://pubmed.ncbi.nlm.nih.gov/40014799/